These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3405336)

  • 1. Factor X-activating activity from Guerin epithelioma.
    Mielicki W; Wierzbicki R
    Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
    Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
    Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
    Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma.
    Roncaglioni MC; Falanga A; D'Alessandro AP; Alessio MG; Casali B; Donati MB
    Haematologica; 1989; 74(2):143-7. PubMed ID: 2501168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
    Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
    Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of divalent ions on the activity of cancer procoagulant.
    Mielicki WP; Kozwich DL; Kramer LC; Gordon SG
    Arch Biochem Biophys; 1994 Oct; 314(1):165-70. PubMed ID: 7944389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A factor X-activating cysteine protease from malignant tissue.
    Gordon SG; Cross BA
    J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant.
    Mielicki WP; Gordon SG
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):441-6. PubMed ID: 8329571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer procoagulant--CP.
    Rucińska M; Gacko M; Skrzydlewski Z
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of cancer procoagulant.
    Mielicki WP
    Haemostasis; 2001; 31 Suppl 1():8-10. PubMed ID: 11990487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Screening of Synthetic Fluorogenic Substrates for Detection of Cancer Procoagulant Activity.
    Krause J; Frost CL
    Protein J; 2018 Apr; 37(2):151-163. PubMed ID: 29411223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
    Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
    Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.
    Kamocka M; Pollard M; Suckow M; Mielicki WP; Rosen ED
    Comp Med; 2008 Jun; 58(3):282-6. PubMed ID: 18589871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
    Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
    Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer procoagulant in serum of rats during development of experimental epithelioma.
    Mielicki W; Wierzbicki R
    Int J Cancer; 1990 Jan; 45(1):125-6. PubMed ID: 2298496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of sodium ion binding on factor IXa activity.
    Gopalakrishna K; Rezaie AR
    Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losac, a factor X activator from Lonomia obliqua bristle extract: its role in the pathophysiological mechanisms and cell survival.
    Alvarez Flores MP; Fritzen M; Reis CV; Chudzinski-Tavassi AM
    Biochem Biophys Res Commun; 2006 May; 343(4):1216-23. PubMed ID: 16597435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.
    Amirkhosravi M; Francis JL
    Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a cysteine protease responsible for degradation of sperm histones during male pronucleus remodeling in sea urchins.
    Imschenetzky M; Díaz F; Montecino M; Sierra F; Puchi M
    J Cell Biochem; 1997 Dec; 67(3):304-15. PubMed ID: 9361186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer procoagulant (CP)].
    Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
    Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.